Cargando…
Designing development programs for non-traditional antibacterial agents
In the face of rising rates of antibacterial resistance, many responses are being pursued in parallel, including ‘non-traditional’ antibacterial agents (agents that are not small-molecule drugs and/or do not act by directly targeting bacterial components necessary for bacterial growth). In this Pers...
Autores principales: | Rex, John H., Fernandez Lynch, Holly, Cohen, I. Glenn, Darrow, Jonathan J., Outterson, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668399/ https://www.ncbi.nlm.nih.gov/pubmed/31366924 http://dx.doi.org/10.1038/s41467-019-11303-9 |
Ejemplares similares
-
Global Pull Incentives for Better Antibacterials: The UK Leads the Way
por: Outterson, Kevin, et al.
Publicado: (2023) -
Incentivizing Antibiotic Development: Why Isn’t the Generating Antibiotic Incentives Now (GAIN) Act Working?
por: Darrow, Jonathan J, et al.
Publicado: (2020) -
The global preclinical antibacterial pipeline
por: Theuretzbacher, Ursula, et al.
Publicado: (2019) -
Non-traditional therapies for diabetes: fact or fiction
por: Forouhar, Elena, et al.
Publicado: (2012) -
Faculty development program evaluation: a need to embrace complexity
por: Fernandez, Nicolas, et al.
Publicado: (2019)